These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 7538955)

  • 1. Pharmacological characterisation of high affinity [35S]GTP gamma S binding in membranes from CHO-K1 cells stably expressing rat D2(short) dopamine receptors.
    Gardner B; Strange PG
    Biochem Soc Trans; 1995 Feb; 23(1):91S. PubMed ID: 7538955
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacological analysis of dopamine stimulation of [35S]-GTP gamma S binding via human D2short and D2long dopamine receptors expressed in recombinant cells.
    Gardner B; Hall DA; Strange PG
    Br J Pharmacol; 1996 Jul; 118(6):1544-50. PubMed ID: 8832084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. G protein activation by human dopamine D3 receptors in high-expressing Chinese hamster ovary cells: A guanosine-5'-O-(3-[35S]thio)- triphosphate binding and antibody study.
    Newman-Tancredi A; Cussac D; Audinot V; Pasteau V; Gavaudan S; Millan MJ
    Mol Pharmacol; 1999 Mar; 55(3):564-74. PubMed ID: 10051542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of [(35)S]GTPgammaS binding to chinese hamster ovary cell membranes by D(2(short)) dopamine receptors.
    Terasmaa A; Finnman UB; Owman C; Ferré S; Fuxe K; Rinken A
    Neurosci Lett; 2000 Feb; 280(2):135-8. PubMed ID: 10686396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [35S]Guanosine-5'-O-(3-thio)triphosphate binding as a measure of efficacy at human recombinant dopamine D4.4 receptors: actions of antiparkinsonian and antipsychotic agents.
    Newman-Tancredi A; Audinot V; Chaput C; Verrièle L; Millan MJ
    J Pharmacol Exp Ther; 1997 Jul; 282(1):181-91. PubMed ID: 9223553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Agonist regulation of D(2) dopamine receptor/G protein interaction. Evidence for agonist selection of G protein subtype.
    Cordeaux Y; Nickolls SA; Flood LA; Graber SG; Strange PG
    J Biol Chem; 2001 Aug; 276(31):28667-75. PubMed ID: 11369753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of the mechanism of agonist and inverse agonist action at D2 dopamine receptors.
    Roberts DJ; Lin H; Strange PG
    Biochem Pharmacol; 2004 May; 67(9):1657-65. PubMed ID: 15081865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological characterization of dopamine-stimulated [35S]-guanosine 5'(gamma-thiotriphosphate) ([35S]GTPgammaS) binding in rat striatal membranes.
    Rinken A; Finnman UB; Fuxe K
    Biochem Pharmacol; 1999 Jan; 57(2):155-62. PubMed ID: 9890563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Real-time analysis of dopamine: antagonist interactions at recombinant human D2long receptor upon modulation of its activation state.
    Pauwels PJ; Tardif S; Wurch T; Colpaert FC
    Br J Pharmacol; 2001 Sep; 134(1):88-97. PubMed ID: 11522600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of the rat D2 and D3 dopamine receptors in insect cells using the baculovirus system.
    Woodcock C; Graber SG; Rooney BC; Strange PG
    Biochem Soc Trans; 1995 Feb; 23(1):93S. PubMed ID: 7758813
    [No Abstract]   [Full Text] [Related]  

  • 11. Agonist-induced [35S]GTPgammaS binding in the membranes of Spodoptera frugiperda insect cells expressing the human D3 dopamine receptor.
    Pregenzer JF; Alberts GL; Im WB
    Neurosci Lett; 1997 Apr; 226(2):91-4. PubMed ID: 9159497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced striatal dopamine D(2) receptor-induced [35S]GTPgammaS binding after haloperidol treatment.
    Geurts M; Hermans E; Maloteaux JM
    Eur J Pharmacol; 1999 Oct; 382(2):119-27. PubMed ID: 10528146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of striatal D1 and D2 dopamine receptor-G protein coupling by agonist-induced [35S]GTP gamma S binding.
    Geurts M; Hermans E; Maloteaux JM
    Life Sci; 1999; 65(16):1633-45. PubMed ID: 10573181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. D2 dopamine receptor-G protein coupling. Cross-regulation of agonist and guanosine nucleotide binding sites.
    Rinken A; Terasmaa A; Raidaru G; Fuxe K
    Neurosci Lett; 2001 Apr; 302(1):5-8. PubMed ID: 11278098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serotonergic agonists behave as partial agonists at the dopamine D2 receptor.
    Rinken A; Ferré S; Terasmaa A; Owman C; Fuxe K
    Neuroreport; 1999 Feb; 10(3):493-5. PubMed ID: 10208577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Agonist and inverse agonist activity at the dopamine D3 receptor measured by guanosine 5'--gamma-thio-triphosphate--35S- binding.
    Malmberg ; Mikaels ; Mohell N
    J Pharmacol Exp Ther; 1998 Apr; 285(1):119-26. PubMed ID: 9536001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histamine H3-receptor-mediated [35S]GTP gamma[S] binding: evidence for constitutive activity of the recombinant and native rat and human H3 receptors.
    Rouleau A; Ligneau X; Tardivel-Lacombe J; Morisset S; Gbahou F; Schwartz JC; Arrang JM
    Br J Pharmacol; 2002 Jan; 135(2):383-92. PubMed ID: 11815373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro biochemical evidence that the psychotomimetics phencyclidine, ketamine and dizocilpine (MK-801) are inactive at cloned human and rat dopamine D2 receptors.
    Jordan S; Chen R; Fernalld R; Johnson J; Regardie K; Kambayashi J; Tadori Y; Kitagawa H; Kikuchi T
    Eur J Pharmacol; 2006 Jul; 540(1-3):53-6. PubMed ID: 16730695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacology of quinpirole-stimulated [35S]GTPgammaS binding: discrepancy with receptor binding profile.
    Gilliland SL; Alper RH; Levant B
    Eur J Pharmacol; 2000 Mar; 392(3):125-8. PubMed ID: 10762663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the ligand binding and signaling properties of human dopamine D(2) and D(3) receptors in Chinese hamster ovary cells.
    Vanhauwe JF; Fraeyman N; Francken BJ; Luyten WH; Leysen JE
    J Pharmacol Exp Ther; 1999 Aug; 290(2):908-16. PubMed ID: 10411608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.